Skip to search formSkip to main contentSkip to account menu

sivelestat

Known as: Glycine, N-(2-(((4-(2,2-dimethyl-1-oxopropoxy)phenyl)sulfonyl)amino)benzoyl)-, N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Neutrophil elastase inhibitor sivelestat ameliorates gefitinib, naphthalene-induced acute pneumonitis in mice. I ntroduction… 
2012
2012
BackgroundThe effects of sivelestat on endotoxin-induced lung injury, postperfusion lung injury, and ischemia–reperfusion are… 
2012
2012
Intrauterine infection and inflammation are recognized as major contributors to the onset of preterm labor. We describe two cases… 
2011
2011
BackgroundRecent evidence has indicated that sivelestat, a neutrophil elastase inhibitor, has liver-protective effects in a… 
2011
2011
We developed a neutrophil elastase-specific near-infrared fluorescence imaging agent, which, combined with fluorescence molecular… 
2010
2010
BACKGROUND Sivelestat, a neutrophil elastase inhibitor, has been used to treat acute lung injury (ALI) with varying levels of… 
2006
2006
PurposeWe assessed the effects of a neutrophil elastase inhibitor, sivelestat, on respiratory and organ functions as well as on… 
2006
2006
Abstract:  Treatment with all‐trans retinoic acid (ATRA) improves the prognosis of patients with acute promyelocytic leukemia… 
2005
2005
Objective:The purpose of this study was to evaluate the effect of a neutrophil elastase inhibitor, sivelestat, on… 
2005
2005
The underlying mechanism involved in the interaction between neutrophil elastase inhibitors and tachykinins has not been…